Tirzepatide with Ixekizumab enhances psoriatic arthritis control in obese patients.
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Abstract
Combining Tirzepatide with Ixekizumab significantly improved disease control in adults with psoriatic arthritis and obesity compared to Ixekizumab alone.